187 related articles for article (PubMed ID: 23707779)
1. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
Yu L; Morishima C; Ioannou GN
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
[TBL] [Abstract][Full Text] [Related]
2. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
Yu L; Morishima C; Ioannou GN
Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
[TBL] [Abstract][Full Text] [Related]
4. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
5. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
[TBL] [Abstract][Full Text] [Related]
6. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
Ghany MG; Lok AS; Everhart JE; Everson GT; Lee WM; Curto TM; Wright EC; Stoddard AM; Sterling RK; Di Bisceglie AM; Bonkovsky HL; Morishima C; Morgan TR; Dienstag JL;
Gastroenterology; 2010 Jan; 138(1):136-46. PubMed ID: 19766643
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
8. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY
J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845
[TBL] [Abstract][Full Text] [Related]
10. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
[TBL] [Abstract][Full Text] [Related]
11. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
13. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine for patients with chronic hepatitis B and advanced liver disease.
Liaw YF; Sung JJ; Chow WC; Farrell G; Lee CZ; Yuen H; Tanwandee T; Tao QM; Shue K; Keene ON; Dixon JS; Gray DF; Sabbat J;
N Engl J Med; 2004 Oct; 351(15):1521-31. PubMed ID: 15470215
[TBL] [Abstract][Full Text] [Related]
15. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
Bruno S; Crosignani A; Facciotto C; Rossi S; Roffi L; Redaelli A; de Franchis R; Almasio PL; Maisonneuve P
Hepatology; 2010 Jun; 51(6):2069-76. PubMed ID: 20196120
[TBL] [Abstract][Full Text] [Related]
16. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area.
Jang ES; Jeong SH; Lee SH; Hwang SH; Ahn SY; Lee J; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kim HY
Liver Int; 2013 Aug; 33(7):1092-9. PubMed ID: 23651110
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
[TBL] [Abstract][Full Text] [Related]
18. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.
Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R
Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492
[TBL] [Abstract][Full Text] [Related]
19. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
Solà R; Alvarez MA; Ballesté B; Montoliu S; Rivera M; Miquel M; Cirera I; Morillas RM; Coll S; Planas R
Liver Int; 2006 Feb; 26(1):62-72. PubMed ID: 16420511
[TBL] [Abstract][Full Text] [Related]
20. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
